Biotech Blog

Biotech Blog

Biotech Blog Archives: September 2004

next page ·

30 September 2004

FDA Eases Rules on Drug Manufacturing

FDA Eases Rules on Drug Manufacturing
“Drug makers will not need regulatory approval for every change in their manufacturing processes under new guidelines designed to prevent supply disruptions, U.S. health officials said on Wednesday.

The modification is part of a just-completed, two-year effort to overhaul regulation of pharmaceutical manufacturing, a major issue for drug makers. “

continue reading... » 0 Comments

28 September 2004

Online Extra: “It’s a Perfect Storm” for Drugmakers

Online Extra: “It’s a Perfect Storm” for Drugmakers: “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company is improving its search for new drugs “

continue reading... » 0 Comments

28 September 2004

“It’s a Perfect Storm” for Drugmakers

It’s a Perfect Storm” for Drugmakers
“Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company is improving its search for new drugs “

continue reading... » 0 Comments

27 September 2004

Long Trip for Psychedelic Drugs

Long Trip for Psychedelic Drugs
“Psychedelic drugs are inching their way slowly but surely toward prescription status in the United States, thanks to a group of persistent scientists who believe drugs like ecstasy and psilocybin can help people with terminal cancer, obsessive-compulsive disorder and post-traumatic stress disorder, to name just a few. “

continue reading... » 0 Comments

21 September 2004

Genetically altered grass spreads like wildfire

Genetically altered grass spreads like wildfire
“A new study shows that genes from genetically engineered grass can spread much farther than previously known, a finding that raises questions about the straying of other plants altered through biotechnology. That could hurt the efforts of two companies to win approval for the first bioengineered grass”

continue reading... » 0 Comments

19 September 2004

How Dublin Keeps Big Pharma Happy

How Dublin Keeps Big Pharma Happy
“It’s moving from basic manufacturing to sophisticated R&D to fend off rivals”

continue reading... » 0 Comments

next page ·